Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Composite medicament used for treating herpes zoster

A herpes zoster and drug technology, which is applied in the field of combined drugs for the treatment of herpes zoster, can solve the problems of slow effect and ineffective treatment effect, and achieve the effect of less medication, less damage to the human body, and faster effect

Inactive Publication Date: 2010-11-24
刘琨
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] In order to overcome the shortcomings of the existing drugs for treating herpes zoster that the therapeutic effect is not obvious and the effect is slow, the present invention proposes a combination drug for treating herpes zoster

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0011] It is composed of 5-10 mL of 2% lidocaine injection, 0.5-1.0 mg of VitB12 injection, 5-10 mg of dexamethasone injection, and 1-2 mL of BCG polysaccharide nucleic acid injection.

[0012] Ingredients and treatment mechanism of the drugs used:

[0013] 1. Lidocaine injection

[0014] Generic name: lidocaine hydrochloride injection

[0015] English name: MLidocaine HydrochMLoride Injection

[0016] Name in Pinyin: Yansuan MLiduokayin Zhusheye

[0017] The main ingredient of this product: lidocaine hydrochloride. Its chemical name is: N-(dichloroxylyl)-2-(diethylamino)acetamide hydrochloride monohydrate.

[0018] Molecular formula: C14H22N20·HCML·H20

[0019] Molecular weight: 288.82

[0020] This product is a colorless and clear liquid.

[0021] This product is an amide local anesthetic. After blood absorption or intravenous administration, it has obvious excitement and inhibitory biphasic effect on the central nervous system, and there may be no precursor excitement. When the blood co...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a composite medicament used for treating herpes zoster. The composite medicament used for treating the herpes zoster is composed of 5 to 10 mL of 2 percent lidocaine injection, 0.5 to 1.0 mg of VitB12 injection, 5 to 10 mg of dexamethasone injection and 1 to 2 mL of bacillus calmette guerin polysaccharide nucleic acid injection. The medicament is used for point injection for treating the herpes zoster. The medicament has the characteristics of quick response, small dosage, safety, high cure rate, good stability and small harm to a human body. The medicament is suitable for treating the herpes zoster.

Description

Technical field [0001] The present invention is a medicine in the field of medicine, especially a combination medicine for treating herpes zoster. Background technique [0002] Shingles is caused by the varicella-zoster virus (VariceMLMLa-virus, VZV). VZV has been named Human Herpes Virus Type 3 (HHV-3). This virus is brick-shaped, has a three-dimensional symmetrical capsid, and contains double-stranded DNA molecules. VZV has weak resistance to the external environment and loses its activity quickly in the dry scab. Chickenpox occurs in children who are immune to the virus. Some patients become infected without symptoms. Because the virus is neuropathic, it can lie in the neurons of the spinal nerve root ganglion for a long time after infection. When the resistance is low or tired, infection, cold and fever, angry and angry, etc., the virus can grow and reproduce again, and along the nerve The fibers move to the skin, causing intense inflammation of the affected nerves and sk...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/715A61K31/714A61K31/573A61K31/167A61K9/08A61P31/22
Inventor 刘琨
Owner 刘琨
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com